¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutrophil activation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® neutrophil ÇÑ±Û Áß¼º±¸
¼³¸í   
  ¿°»ö»ó »êµµ°¡ Áß¼ºÀΠ»óÅ¿¡¼­ ¼¼Æ÷Áú³»¿¡ Á¸ÀçÇϴ ¿©·¯ °ú¸³µéÀÌ ³ªÅ¸³ª±â ¶§¹®¿¡ Áß¼º±¸¶ó°í ºÒ¸®¸ç, ¶ÇÇÑ ¼¼Æ÷³»ÀÇ ÇÙÀÇ ÇüŰ¡ ´Ù¾çÇϹǷΠ´ÙÇü¹éÇ÷±¸¶ó°íµµ ÇÑ´Ù. ±â´ÉÀº ÁַΠ½Åü³»¿¡ Ä§ÀÔÇϴ º´±ÕÀ» Àâ¾Æ¸ÔÀ½À¸·Î½á Ç×±ÕÀÛ¿ëÀ» ¼öÇàÇÑ´Ù.
¿µ¹® activation ÇÑ±Û È°¼º, Ȱ¼ºÈ­
¼³¸í   
  ÀϹÝÀûÀ¸·Î, »ýü³ª »ýü ¹°ÁúÀÌ ±× ±â´ÉÀ» È°¹ßÇϰԠ³ªÅ¸³»°Ô µÇ´Â °Í, ¿¹¸¦ µé¸é ¨ç Ã˸Šµî¿¡¼­, ±× Ç¥¸é »óÅÂÀÇ º¯È­³ª, ´Ù¸¥ ¹°ÁúÀǠ÷°¡ µî¿¡ ÀÇÇÏ¿©, ±× ±â´ÉÀÌ ÇöÀúÇϰԠ³ô¾ÆÁö´Â °Í. ¨è È¿¼ÒÀü±¸Ã¼ÀǠȰ¼ºÈ­·Î¼­ È¿¼ÒÀÛ¿ëÀ» °¡ÁöÁö ¾Ê´Â È¿¼Ò Àü±¸Ã¼°¡ È°¼ºÀִ ȿ¼Ò·Î º¯È­´Â °Í. ¶Ç È²È­¼ö¼Ò³ª ½Ã¾ÈÈ­¼ö¼Ò»ê µîÀ¸·Î ÆÄÆÄÀÎÀ̠Ȱ¼ºÈ­µÇ´Â °æ¿ìµµ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • band neutrophil
    ¶ìÁß¼º±¸
  • hypersegmented neutrophil
    °ú´ÙºÐ¿±ÇÙÁß¼º±¸
  • juvenile neutrophil
    ¼Ò¾ÆÁß¼º±¸, ÃʱâÁß¼º±¸
  • neutrophil
    Áß¼º±¸, È£Áß±¸
  • neutrophil chemotactic factor
    Áß¼º±¸È­ÇÐÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
  • neutrophil granule
    È£Áß¼º°ú¸³
  • neutrophil leukocyte
    Áß¼º¹éÇ÷±¸, È£Áß¹éÇ÷±¸
  • nonfilamented neutrophil
    ¹«¹Ì¼¼¼¶À¯Áß¼º±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÁß¼º±¸
  • activation
    Ȱ¼ºÈ­
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • activation energy
    Ȱ¼ºÈ­¿¡³ÊÁö
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • activation gate
    °³¹æ°ü¹®
  • activation process
    Ȱ¼ºÈ­°úÁ¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activation
    Ȱ¼º, Ȱ¼ºÈ­, ´Éµ¿È­
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • neutrophil
    Áß¼º±¸
  • band neutrophil
    ¶ìÁß¼º±¸
  • hypersegmented neutrophil
    °ú´ÙºÐ¿±ÇÙÁß¼º±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÁß¼º±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • band neutrophil
    ¶ìÈ£Áß±¸
  • neutrophil chemotactic factor
    È£Áß±¸ÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
  • neutrophil granule
    È£Áß±¸µ¶¼º°ú¸³
  • hypersegmented neutrophil
    °ú´ÙºÐȹȣÁß±¸
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸, ÃʱâÈ£Áß±¸
  • neutrophil leukocyte
    È£Áß¼º¹éÇ÷±¸
  • neutrophil
    È£Áß¼º¹éÇ÷±¸, È£Áß±¸
  • nonfilamented neutrophil
    ¹«¹Ì¼¼¼¶À¯È£Áß±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÈ£Áß±¸
  • activation
    Ȱ¼º, Ȱ¼ºÈ­
  • activation detector
    Ȱ¼ºÈ­Å½Áö±â
  • activation energy
    Ȱ¼º¿¡³ÊÁö
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • activation gate
    °³¹æ°ü¹®
  • activation process
    Ȱ¼ºÈ­°úÁ¤
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymorphonuclear neutrophil =PMN
    ´ÙÇüÇ٠ȣÁß±¸
  • polymorphonuclear neutrophil[e]
    ´ÙÇÙÈ£Áß±¸
  • activation
    Ȱ¼ºÈ­(üÀàõûù).
  • activation
    Ȱ¼ºÈ­
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • activation detector
    Ȱ¼ºÈ­ ŽÁö±â
  • activation energy
    Ȱ¼ºÈ­¿¡³ÊÁö
  • activation gate
    °³¹æ °ü¹®(ËÒÛÁμڦ)
  • activation process
    Ȱ¼ºÈ­°úÁ¤.
  • activation, polyclonal
    ´Ù¼¼Æ÷±ºÈ°¼º, ¿©·¯¹«¸®È°¼º
  • activation, polyclonal B cell
    ´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
  • heat of activation
    Ȱ¼ºÈ­¿­(üÀàõûýæð)
  • photochemical activation
    ±¤È°¼ºÈ­(Ë´Ì· ËÛÌ´).
  • plasmin activation inhibitor
    Çö󽺹ÎȰ¼ºÈ­¾ïÁ¦Á¦(¡­üÀàõûùåäð¤ð¥)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • band neutrophil
    ´ëÈ£Áß±¸(Óáû¿ñéϹ)
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸(ËôËâ̴̡˴) Èİñ¼ö±¸(Ì·Ë­ËàË´) .
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸(êêå´û¿ñéϹ) Èİñ¼ö±¸(ý­ÍéâÐϹ) .
  • neutrophil
    È£Áß±¸
  • neutrophil
    È£Áß±¸(̴̡˴), È£Áß¼º(Ì´Ì¡ËÛ) ÀÇ, Áß¼ºÄ£È­(¼º)(Ì¡ËÛ̴̬ËÛ)ÀÇ.
  • neutrophil
    È£Áß±¸, È£Áß¼º
  • neutrophil
    È£Áß?û¿ñéϹ), È£Áß¼º(û¿ñéàõ) ÀÇ, Áß¼ºÄ£È­(¼º)(ñéàõöÑûúàõ)ÀÇ.
  • neutrophil
    È£Áß±¸
  • neutrophil
    È£Áß±¸(û¿ñéϹ)
  • neutrophil alkaline phosphatase
    È£Áß±¸¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦
  • neutrophil chemotactic factor
    È£Áß¼º(û¿ñéàõ)ÀÇ, Áß¼ºÄ£È­¼º(ñéàõöÑûúàõ)ÀÇ
  • neutrophil chemotactic factor(NCF)
  • neutrophil granule
    È£Áß¼º °ú¸³(~?Ëö), Áß¼ºÄ£È­(¼º) °ú¸³.
  • neutrophil kinetics
    È£Áß¼º Ű³×ƽ½º, È£Áß¼º µ¿ÅÂ(~ËÄ̬).
  • neutrophil leucocyte
    È£Áß¼º ¹éÇ÷±¸(Ì´Ì¡ËÛËÑÌ´Ë´).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activation
    Ȱ¼ºÈ­ (üÀàõûù)
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼® (üÀàõûùÝÂà°)
  • activation energy
    Ȱ¼ºÈ­(üÀàõûù)¿¡³ÊÁö
  • activation stage
    Ȱ¼ºÈ­±â(üÀàõûùÑ¢)
  • amino acid activation
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù)
  • Arrenius activation energy
    ¾Æ·¹´Ï¿ì½º Ȱ¼º(üÀàõ)¿¡³ÊÁö
  • complement activation
    º¸Ã¼ Ȱ¼ºÈ­(ÜÍô÷üÀàõûù)
  • contact activation cofactor
    "Á¢ÃËȰ¼º º¸ÀÎÀÚ(ïÈõºüÀàõÜÍì×í­), (ÔÒ) high molecular weight kininogen"
  • energy of activation
    Ȱ¼ºÈ­(üÀàõûù) ¿¡³ÊÁö
  • fatty acid activation
    Áö¹æ»ê Ȱ¼ºÈ­ (ò·Û¸ß«üÀàõûù)
  • feed-forward activation
    ¾Õ¸ÔÀÓ È°¼ºÈ­ (üÀàõûù)
  • gene activation
    À¯ÀüÀÚ È°¼ºÈ­(ë¶îîí­üÀàõûù)
  • macrophage activation factor
    ´ë½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ(ÓÞãÝá¬øàüÀàõì×í­)
  • neutron activation alalysis
    Áß¼ºÀÚ ¹æ»çÈ­ºÐ¼®(ñéàõí­Û¯ÞÒûùÝÂà°)
  • reciprocal activation
    »óº¸ Ȱ¼ºÈ­(ßÓÜÍüÀàõûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutrophil
    È£Áß±¸, È£Áß¼ºÀÇ, Áß¼ºÄ£È­(¼º)ÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMNA complement-mediated neutrophil activation
NAA N-acetyl aspartate; naphthaleneacetic acid; neutral amino acid; neutron activation analysis; neutrop...
NAP nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne...
RAS   1) Reticular Activating(Activation) System
  2) Renal Artery Stenosis
VAT   1) Ventricular Activation Time
  2) Video-Assisted Thoracoscopy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CINC 8/cytokine-induced neutrophil chemoattractant
ANC Absolute Neutrophil Count
ANCA Anti-Neutrophil Cytoplasmic Antibodies
ANCA Anti-Neutrophil Cytoplasmic Antibody
ANCA Anti-neutrophil cytoplasm antibodies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • juvenile neutrophil
    À¯¾à È£Áß±¸
  • neutrophil
    È£Áß±¸, È£Áß¼ºÀÇ, Áß¼º ģȭÀÇ, Áß¼º ģȭ¼ºÀÇ
    1. °ñ¼ö ¼Ó¿¡¼­ Çü¼ºµÇ´Â ¹éÇ÷±¸ÀÇ ÀÏÁ¾À¸·Î ³»ºÎ¿¡ Áß¼º ¿°»ö¼º °ú¸³À» Æ÷ÇÔÇϰí ÀÖ´Ù. 2. Áß¼º »ö¼Ò·Î ½±°Ô ¿°»öµÇ´Â ¸ðµç ¼¼Æ÷, ±¸Á¶¹° ¶Ç´Â Á¶Á÷ ¼ººÐ. 3. â»ó ºÎÀ§¿¡ óÀ½À¸·Î µé¾î¿À´Â ¿°Áõ ¼¼Æ÷·Î¼­ ¼ö¸íÀÌ Âª¾Æ Á¶Á÷ÀÌ ¼Õ»óÀ» ¹ÞÀº ÈÄ ¸î ½Ã°£ À̳»¿¡ ÃâÇöÇÏ¿© 24½Ã°£ ÈÄ ÃÖ°íÁ¶¿¡ ´ÞÇÏ´Ù°¡ °ð º¯¼ºµÇ¾î ¾ø¾îÁø´Ù.
  • neutrophil dysfunction syndrome
    È£Áß±¸ ±â´É Àå¾Ö ÁõÈıº
  • neutrophil granule
    È£Áß¼º °ú¸³, Áß¼º ģȭ °ú¸³, Áß¼º ģȭ¼º °ú¸³
  • neutrophil leucocyte
    È£Áß¼º ¹éÇ÷±¸, Áß¼º È£¼º ¹éÇ÷±¸
    »ýü¿¡¼­ 7-9§­, µµ¸» Ç¥º»¿¡¼­ 10-12§­ÀÇ Á÷°æÀ» °®°í ÀÖ´Ù. ÇÙÀÇ ¸ð¾çÀº ´Ù¾çÇÑ ºÐ¿± »óŸ¦ ÀÌ·ç´Âµ¥, ºÐ¿±ÀÇ ¼ö´Â 3-5°³ÀÌ°í ºÐ¿± ÇÙ³¢¸®´Â ¹Ì¼¼ÇÑ ¿°»ö»ç·Î ¿¬°áµÇ¾î ÀÖÀ¸¸ç ÇÙ ¼Òü´Â °üÂûµÇÁö ¾Ê´Â´Ù.
  • segmented neutrophil
    ºÐÀý±¸ ÇÙ
    °¡Àå ºÐÈ­ ¼º¼÷µÈ ÇüÅÂÀÇ È£Áß±¸.
  • activation
    Ȱ¼ºÈ­
    Ȱ¼ºÈ­ÇÏ´Â ÀÛ¿ëÀ̳ª °úÁ¤.
  • activation of muscle
    ±ÙÀ°ÀÇ È°¼ºÈ­
    ±ÙÀ° Á¶Á÷À¸·Î ¿¡³ÊÁö°¡ ¹æÃâµÇ¾î ±ÙÀ°ÀÇ ¼öÃàÀ» ÀÏÀ¸Å°´Â °Í.
  • activation process
    Ȱ¼ºÈ­ °úÁ¤
  • co-activation
    »óÈ£ Ȱ¼º
  • complement activation
    º¸Ã¼ Ȱ¼º ÀÛ¿ë, º¸Ã¼ Ȱ¼ºÈ­
  • heat of activation
    Ȱ¼ºÈ­ ¿­
  • polyclonal activation
    ´Ù¼ö Ŭ·Ð Ȱ¼º
  • receptor activation
    ¼ö¿ëü Ȱ¼ºÈ­, ¼ö¿ë±â Ȱ¼ºÈ­
  • secondary activation
    ÀÌÂ÷Àû Ȱ¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
neutrophil activation The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonised particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anionic neutrophil activating peptide <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
band neutrophil <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
mature neutrophil A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion.
Synonym: mature neutrophil.
(05 Mar 2000)
monocyte derived neutrophil chemotactic factor <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
segmented neutrophil A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion.
Synonym: mature neutrophil.
(05 Mar 2000)
hypersegmented neutrophil An aged and degenerated neutrophil in which there may be 6 to 10 lobes in the nucleus.
Immature neutrophil, a young neutrophil; the term is usually used with reference to stab neutrophil's (or other "juvenile" neutrophil's), neutrophilic granulocytes in which the nucleus is indented but not distinctly segmented.
Juvenile neutrophil, any cell of the granulocytic series in which the neutrophilic granules are recognizable and the nucleus is indented (the first phase of segmentation).
(05 Mar 2000)
stab neutrophil <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
neutrophil <haematology> A granulocyte, a white blood cell.
(18 Nov 1997)
neutrophil activating factor <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
neutrophil activating protein <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
neutrophil chemotactant factor <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
neutrophil collagenase <enzyme> Cleaves interstitial collagens in the triple helical domain; cleaves type I collagen more rapidly than type III; fibroblast collagenase cleaves at the same site as neutrophil colagenase
Registry number: EC 3.4.24.34
Synonym: matrix metalloproteinase 8, mmp-8, mmp 8, fibroblast collagenase
(26 Jun 1999)
neutrophil granule A granule stainable with the neutral component of stains, e.g., the Romanovsky-type blood stains.
(05 Mar 2000)
activation <radiobiology> Activation occurs when a particle interacts with an atomic nucleus, shifting the nucleus into an unstable state, and causing it to become radioactive.
In fusion research, where deuterium-tritium is a common fuel mixture, the neutron released when (D + T) combine to form (4He + n) can activate the reactor structure. In this case the 4He is inert, the neutron sticks to another nucleus, and the neutron + nucleus reaction creates an actvation product. Sometimes called radioactivation.
See: activation product, activation analysis.
(09 Oct 1997)
activation analysis <radiobiology> Method for identifying and measuring chemical elements in a sample of material. Sample is first made radioactive by bombardment with neutrons, charged particles, or gamma rays.
Newly formed radioactive atoms in the sample then give off characteristic radiations (such as gamma rays) that tell what kinds of atoms are present, and how many.
(09 Oct 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Neutrophil Activation - »õâ The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.
    Synonyms : Activation, Neutrophil, Activations, Neutrophil, Neutrophil Activations
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activation
    Ȱµ¿ÀûÀ¸·Î Çϱâ;Ȱ¼ºÈ­;ºÎ´ë ½Å¼³(Æí¼º)
  • neutron activation analysis
    Áß¼ºÀÚ(À¯µµ)¹æ»çÈ­ ºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á